Panobinostat - PDFSEARCH.IO - Document Search Engine

Panobinostat
Results: 11

#	Item
1	Anti-AML activity of combined epigenetic therapy with novel DNMT1 inhibitors SGI-110 and SGI1036 and histone deacetylase inhibitor panobinostat. Warren Fiskus1, Pace Johnston1, Rajeshree Joshi1, Rekha Rao1, Celalettin Us Add to Reading List Source URL: astx.com Language: English Molecular biology Proteins DNA methyltransferase Developmental biology DNA methylation Actin K562 cells Cellular differentiation Histone deacetylase inhibitor Biology Genetics Epigenetics
2	OPEN Citation: Cell Death and Disease[removed], e798; doi:[removed]cddis[removed] & 2013 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis Add to Reading List Source URL: www.nature.com Language: English - Date: 2013-09-12 09:54:10 Apoptosis Peripheral membrane proteins Protein families Indoles Panobinostat Histone deacetylase inhibitor Bcl-2 Annexin Myc Biology Cell biology Programmed cell death
3	Bauer et al Phase I panobinostat plus imatinib in GIST Add to Reading List Source URL: www.gistsupport.org Language: English - Date: 2013-01-18 17:48:13 Piperazines Pyrimidines Imatinib Pyridines Indoles Panobinostat Gastrointestinal stromal tumor Leukemia Thrombocytopenia Medicine Organic chemistry Chemistry
4	FARYDAK (panobinostat) histone deactylase inhibitor Add to Reading List Source URL: www.fda.gov Language: English
5	ASCO[removed]Clinical response by baseline characteristics in patients with relapsed and bortezomib-refractory multiple myeloma treated with panobinostat, bortezomib, and dexamethasone (PANORAMA 2) Melissa Alsina,1 Paul G. Add to Reading List Source URL: myeloma.org Language: English - Date: 2013-06-10 19:40:25 Immunosuppressants Orphan drugs Amides Bortezomib Pyrazines Lenalidomide Multiple myeloma Dexamethasone Mantle cell lymphoma Medicine Chemistry Organic chemistry
6	MOLECULAR CYTOGENETICS IN WALDENSTRÖM’S MACROGLOBULINEMIA Add to Reading List Source URL: myeloma.org Language: English - Date: 2012-04-18 11:54:23 Immunosuppressants Indoles Panobinostat Lenalidomide Multiple myeloma Bortezomib Histone deacetylase inhibitor Dexamethasone PD-1 Medicine Chemistry Organic chemistry
7	FDA ONCOLOGIC DRUGS ADVISORY COMMITTEE BRIEFING DOCUMENT Panobinostat capsules ODAC Meeting Date: 6 November 2014 Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Orphan drugs Hematologic neoplasms Bortezomib Pyrazines Lenalidomide Panobinostat Carfilzomib Histone deacetylase inhibitor Medicine Chemistry Organic chemistry
8	NDA[removed]panobinostat (Farydak) ODAC Brief FDA Briefing Document Add to Reading List Source URL: www.fda.gov Language: English Clinical research Pharmacology Medical statistics Design of experiments Evaluation methods Multiple myeloma Bortezomib Panobinostat End point of clinical trials Medicine Research Science
9	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Orphan drugs Amides Bortezomib Pyrazines Multiple myeloma Dexamethasone Panobinostat End point of clinical trials Plasma cell leukemia Chemistry Organic chemistry Medicine
10	FOOD AND DRUG ADMINISTRATION Add to Reading List Source URL: www.fda.gov Language: English Orphan drugs Amides Bortezomib Pyrazines Multiple myeloma Dexamethasone Panobinostat End point of clinical trials Plasma cell leukemia Chemistry Organic chemistry Medicine

UPDATE